Join us for

Building a Healthier Future with Technology

Building a Healthier Future with Technology Flyer
Details:
April 1, 2020
10:00 am
REGISTER HERE:
RSVP
JOIN US HERE:
LINK TO WEBINAR
Did you miss it?
VIEW RECAP
Description:

Now more than ever it is important that we stick together as a community and offer the resources, support, and tools we need to be successful and healthy. As a startup ourselves, we understand this is a specially difficult time to be starting or scaling a business and we want to offer the startup community valuable resources.

Join us for a virtual panel as we bring together a roundtable of experts and industry leaders in biotech and public health to learn about the strides the industry is making and the industry’s responsibility in a time like this. We will discuss progress in data tracking, the growth and impact in the biotech sector, how this current virus will affect the startup ecosystem, and more.

Meet The Panelists:
Noelle Tassey
CEO
Alley

Noelle Tassey is currently the CEO of Alley. She has spent almost a decade working to scale growth-stage technology businesses, and launching new ventures. She also advises and invests in a variety of early-stage companies, and she is committed to building a more equal future through technology. Under her leadership, Alley has been named to Inc. 5000 Fastest Growing Companies and Inc. Best Places to Work.

Justin Zhou
Co-founder and President
Bluewave

Justin Zhou is the Co-Founder and President of BLUEWAVE Technologies, Inc., a venture backed health-tech startup and creator of the BLUEWAVE, a device designed to kill bacteria and viruses with its proprietary ozone infusion technology. It is a dry, room-temperature process using no water, detergents, or added chemicals. The device is closed-loop and removes excess ozone upon completing the treatment. In the testing conducted to date, the BLUEWAVE device kills 99.999% and 99.91% of MS2 Bacteriophage Virus, a non-enveloped virus, in under 10 minutes on stainless steel surfaces and 2-ply porous polyester fabric, respectively. He has more than 10 years’ experience in the technology industry. Before co-founding BLUEWAVE, Justin specialized in high-powered battery electrodes at a startup with the rest of BLUEWAVE’s management team. He earned his B.S. and M.S. in Materials Science & Engineering from the University of Florida.

Yaniv Sneor
Co-founder
MidAtlanticBioAngels

Yaniv Sneor is one of the founders of MABA – Mid Atlantic Bio Angels (bioangels.net) a life science angel investor group, where he also administers MABA’s internal investment pools, and MABA’s co-investment Sidecar Fund, for non MABA member investors. Mr. Sneor is also Chief Executive Officer of Native State Therapeutics, an early state biotechnology company in the neurodegeneration field, and President of Blue Cactus Consulting (bluecactusconsulting.com) a business strategy consulting group. Yaniv Sneor is originally a physicist, who made the transition into the business world about 30 years ago, at which point he took the helm of his first company. Mr. Sneor has senior merger, acquisition, capitalization, turnaround leadership experience with companies ranging from start-up to growth. He has held positions of CEO, COO, President, and General Manager at a number of companies, including a bio-informatics company, a surgical laser company, a manufacturing and distribution company, a software and network integration company, and several others. Mr. Sneor has mentored numerous life science and technology start-ups through BiomedX (formerly, the Columbia-Coulter Translational Research Partnership), the Bench-to-Bedside Initiative jointly sponsored by Weill-Cornell Medical Center, and the E-Lab for Life Science Entrepreneurs sponsored in part by the New York City Economic Development Corporation. Until recently, Mr. Sneor was a member of the Board of Trustees of the Institute for Life Science Entrepreneurship, is currently a member of the NJ EDA’s Technology Advisory Board, and a past Chairman of the NJ chapter of the Licensing Executives Society (LES).

David Narrow
Co-founder and CEO
Sonavex

David Narrow is co-founder and CEO of Sonavex Inc., a venture-backed commercial stage medical device company spun-out of Johns Hopkins University, which has raised over $14M. The company develops and commercializes ultrasound products for surgeons, including a technology for detecting post-operative vascular complications. His first venture, MonoMano Inc., provides rehabilitative, general health, and social benefits to stroke survivors by making cycling accessible for those with functional use of a single arm and leg. David previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy as a healthcare consultant at Health Advances LLC. Narrow earned his B.S. in Biomedical Engineering with Highest Distinction from the University of Rochester before receiving his Masters from Johns Hopkins University. Narrow was named 30 Under 30 in Healthcare by Forbes in 2016, 40 Under 40 by the Baltimore Business Journal in 2017, and recognized as Baltimore’s Top BioHealth Startup CEO in 2019.

Our Partners:

Verizon 5G Labs

Verizon's 5G Labs works with startups, academia and enterprise teams to build a 5G-powered world. We work on 5G trials, hackathons, industry partnerships, prototyping challenges and more.

By purchasing or reserving a ticket for an event, you are agreeing to our terms and conditions. We collect your information to provide the best experience possible. By signing up for this event you agree to future communication from Alley & our cohosts. We comply with EU’s privacy policy GDPR guidelines. For more information on our privacy policy please visit our privacy policy.

Details:
April 1, 2020
10:00 am
REGISTER HERE:
RSVP
Private Event:
JOIN OUR NEWSLETTER
JOIN US HERE:
LINK TO WEBINAR
Did you miss it?
VIEW RECAP